NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in NRX Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +6 vs. Q2 2021
- Shares held
- 1.75M
- +114.0K (+7.0%) vs. Q2 2021
- Total value
- $16.2M
- −$2.70M (−14.3%) vs. Q2 2021
- New holders
- 14
- 7 more added
- Sold out
- 8
- 1 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRXP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $47.6M |
| Q1 2026 | 33 | $13.2M |
| Q4 2025 | 28 | $14.2M |
| Q3 2025 | 24 | $13.0M |
| Q2 2025 | 25 | $9.76M |
| Q1 2025 | 22 | $4.60M |
| Q4 2024 | 25 | $2.31M |
| Q3 2024 | 18 | $1.21M |
| Q2 2024 | 19 | $1.29M |
| Q1 2024 | 31 | $1.76M |
| Q4 2023 | 30 | $1.84M |
| Q3 2023 | 34 | $964.7K |
| Q2 2023 | 32 | $4.78M |
| Q1 2023 | 30 | $2.07M |
| Q4 2022 | 33 | $3.44M |
| Q3 2022 | 30 | $3.04M |
| Q2 2022 | 37 | $2.18M |
| Q1 2022 | 34 | $25.1M |
| Q4 2021 | 38 | $12.4M |
| Q3 2021 | 23 | $16.2M |
| Q2 2021 | 18 | $18.9M |
| Q1 2021 | 1 | $4.00K |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding NRX Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,000,123 | $9.27M | 0.00% | +362,707+56.9% | Added |
| Cambridge Investment Research Advisors, Inc. | 153,523 | $1.42M | 0.01% | +153,523 | New |
| Citadel Advisors LLC | 135,087 | $1.25M | 0.00% | +135,087 | New |
| Jane Street Group, LLC | 77,032 | $714.0K | 0.00% | +77,032 | New |
| Susquehanna International Group, LLP | 55,328 | $513.0K | 0.00% | +55,328 | New |
| Owl Creek Asset Management, L.P. | 50,000 | $464.0K | 0.03% | −250,000−83.3% | Reduced |
| Geode Capital Management, LLC | 45,766 | $424.0K | 0.00% | +11,291+32.8% | Added |
| HighPoint Advisor Group LLC | 43,501 | $403.0K | 0.04% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 42,885 | $398.0K | 0.00% | +39,580+1,197.6% | Added |
| Wolverine Asset Management LLC | 42,568 | $394.0K | 0.00% | +23,078+118.4% | Added |
| Morgan Stanley | 41,052 | $381.0K | 0.00% | +1,183+3.0% | Added |
| Bank of America Corp | 19,362 | $179.0K | 0.00% | +19,362 | New |
| Murchinson Ltd. | 17,900 | $166.0K | 0.08% | +17,900 | New |
| Group One Trading, L.P. | 7,574 | $70.0K | 0.00% | +7,574 | New |
| Cutler Group LP | 7,451 | $69.0K | 0.01% | +7,451 | New |
| Wells Fargo & Company | 5,000 | $46.0K | 0.00% | +5,000 | New |
| Penserra Capital Management LLC | 2,956 | $27.0K | 0.00% | +2,956 | New |
| Quantbot Technologies LP | 1,565 | $14.0K | 0.00% | +1,565 | New |
| Tower Research Capital LLC (TRC) | 1,026 | $10.0K | 0.00% | +895+683.2% | Added |
| Jacobi Capital Management LLC | 1,000 | $9.00K | 0.00% | +1,000 | New |
| Citigroup Inc | 479 | $4.00K | 0.00% | +394+463.5% | Added |
| JPMorgan Chase & Co | 212 | $2.00K | 0.00% | +212 | New |
| Larson Financial Group LLC | 218 | $2.00K | 0.00% | +218 | New |
| Linden Advisors LP | 0 | $0 | 0.00% | −364,352−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −130,633−100.0% | Sold out |
| Ionic Capital Management LLC | 0 | $0 | 0.00% | −35,721−100.0% | Sold out |
| Yakira Capital Management, Inc. | 0 | $0 | 0.00% | −11,923−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −8,385−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Stonebridge Financial Planning Group, LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |